NRM-823

· Normunity AccelCo, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NRM-823, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors [Phase 1]